István Likó Selected Research

Lapatinib (GW572016)

1/2013

Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

István Likó Research Topics

Disease

6	Neoplasms (Cancer) 05/2019 - 09/2009
5	Inflammation (Inflammations) 10/2015 - 07/2011
4	Pituitary Neoplasms (Pituitary Adenoma) 05/2019 - 10/2010
4	Adenoma (Adenomas) 05/2019 - 09/2009
2	Adrenocortical Adenoma (Disease, Conn's) 10/2021 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 05/2005
2	Adrenocortical Carcinoma 01/2018 - 09/2009
2	Carcinogenesis 07/2017 - 10/2010
2	Cushing Syndrome 02/2013 - 11/2009
1	Perivascular Epithelioid Cell Neoplasms 01/2022
1	Cognitive Dysfunction 01/2019
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Myelolipoma 01/2018
1	Glucocorticoid Receptor Deficiency 01/2018
1	Peritonitis 05/2015
1	Obesity 02/2013
1	Osteoporosis 02/2013
1	Type 2 Diabetes Mellitus (MODY) 02/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2012
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 12/2010
1	Pheochromocytoma 12/2010
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2010
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 12/2010
1	Mental Disorders (Mental Disorder) 03/2010

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 10/2021 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 05/2019 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 07/2017 - 10/2010
2	Formaldehyde (Formol)FDA Link 01/2018 - 12/2010
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018 - 11/2009
2	ParaffinIBA 01/2018 - 12/2010
2	Phosphotransferases (Kinase)IBA 07/2017 - 10/2010
2	Freund's AdjuvantIBA 10/2015 - 05/2015
2	Caveolin 1IBA 05/2015 - 01/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2013 - 09/2009
2	Estrogens (Estrogen)FDA Link 07/2011 - 03/2010
2	Messenger RNA (mRNA)IBA 10/2010 - 09/2009
1	NucleotidesIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	SteroidsIBA 10/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	Anterior Pituitary HormonesIBA 05/2019
1	Transcription Factors (Transcription Factor)IBA 05/2019
1	Codon (Codons)IBA 01/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019
1	EnzymesIBA 02/2013
1	Sunitinib (Sutent)FDA Link 01/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013
1	Epithelial Cell Adhesion MoleculeIBA 01/2013
1	Gefitinib (Iressa)FDA Link 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 01/2013
1	Tyrosine Kinase InhibitorsIBA 01/2013
1	Lapatinib (GW572016)FDA Link 01/2013
1	Complement C5a (Complement 5a)IBA 05/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	NAD (NADH)IBA 07/2011
1	2,3-bis(4-hydroxyphenyl)-propionitrileIBA 07/2011
1	Biological ProductsIBA 06/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2010
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2010
1	ProlactinIBA 10/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2010
1	Gonadal HormonesIBA 03/2010
1	Amyloid beta-PeptidesIBA 05/2005
1	Blood Proteins (Serum Proteins)IBA 05/2005
1	Serum Amyloid P-ComponentIBA 05/2005

Therapy/Procedure

1	Therapeutics 01/2013
1	Drug Therapy (Chemotherapy) 01/2012